Ripa S, Ferrante L, Prenna M
Department of MCA Biology, Faculty of Pharmacy, University of Camerino, Italy.
Chemotherapy. 1993;39(1):6-12. doi: 10.1159/000238967.
The pharmacokinetic profile of fluconazole, after 100 mg i.v. infusion or oral administration of a single 50 mg or 150 mg dose, was investigated in 18 healthy volunteers. At a dose of 100 mg i.v., the half-life (t1/2 beta) was 29.73 +/- 8.05h. The mean residence time in the plasma was 27.56 +/- 5.98 h. The post-distributive volume V beta = 52.16 +/- 9.83 l, approximating that of total body water. Renal excretion accounted for 61.64 +/- 8.80% of the drug elimination after 48 h, with renal clearance Clr = 12.91 +/- 2.83 ml/min. Plasma clearance (Clp) was 21.03 +/- 5.07 ml/min. At oral doses of 50 and 150 mg the distribution and elimination of fluconazole resembled that following i.v. infusion. The peak levels in plasma at 2.5 h were 0.93 +/- 0.13 and 2.69 +/- 0.43 micrograms/ml, respectively. The large distribution volume, the long half-life and mean residence times, combined with a rapid absorption after oral administration, suggest that fluconazole will be effective at a wide range of body sites.
在18名健康志愿者中研究了氟康唑在静脉输注100mg或口服单次50mg或150mg剂量后的药代动力学特征。静脉注射100mg剂量时,半衰期(t1/2β)为29.73±8.05小时。血浆平均驻留时间为27.56±5.98小时。分布后体积Vβ=52.16±9.83升,接近总体液量。48小时后,肾脏排泄占药物消除的61.64±8.80%,肾脏清除率Clr=12.91±2.83ml/分钟。血浆清除率(Clp)为21.03±5.07ml/分钟。口服50mg和150mg剂量时,氟康唑的分布和消除与静脉输注后相似。2.5小时时血浆峰值水平分别为0.93±0.13和2.69±0.43μg/ml。分布体积大、半衰期和平均驻留时间长,加上口服给药后吸收迅速,表明氟康唑在广泛的身体部位均有效。